Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary Neoplasms | 265 | 2024 | 1345 | 26.490 |
Why?
|
Adenoma | 177 | 2024 | 2174 | 13.580 |
Why?
|
Sphenoid Bone | 69 | 2020 | 172 | 10.100 |
Why?
|
Neurosurgical Procedures | 76 | 2021 | 2002 | 8.680 |
Why?
|
Sella Turcica | 49 | 2019 | 119 | 7.350 |
Why?
|
Pituitary Gland | 58 | 2023 | 665 | 7.090 |
Why?
|
Craniopharyngioma | 36 | 2021 | 281 | 6.170 |
Why?
|
Pituitary ACTH Hypersecretion | 28 | 2023 | 175 | 6.130 |
Why?
|
Skull Base | 19 | 2018 | 306 | 5.710 |
Why?
|
Neurosurgery | 41 | 2021 | 643 | 4.920 |
Why?
|
Endoscopy | 32 | 2022 | 1787 | 4.460 |
Why?
|
Sphenoid Sinus | 28 | 2017 | 99 | 4.390 |
Why?
|
Pituitary Diseases | 29 | 2019 | 141 | 3.960 |
Why?
|
Acromegaly | 38 | 2021 | 347 | 3.690 |
Why?
|
Neuroendoscopy | 8 | 2019 | 105 | 3.660 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 13 | 2023 | 61 | 3.590 |
Why?
|
Central Nervous System Cysts | 11 | 2021 | 58 | 3.380 |
Why?
|
Nasal Cavity | 15 | 2019 | 313 | 2.840 |
Why?
|
Prolactinoma | 13 | 2019 | 113 | 2.780 |
Why?
|
Hypophysectomy | 23 | 2018 | 113 | 2.730 |
Why?
|
Skull Base Neoplasms | 14 | 2021 | 284 | 2.700 |
Why?
|
Pituitary Apoplexy | 10 | 2016 | 30 | 2.310 |
Why?
|
Cushing Syndrome | 23 | 2010 | 249 | 2.250 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 14 | 2016 | 80 | 2.210 |
Why?
|
Microsurgery | 25 | 2014 | 796 | 2.150 |
Why?
|
Radiosurgery | 26 | 2011 | 1329 | 1.680 |
Why?
|
Postoperative Complications | 72 | 2019 | 15297 | 1.630 |
Why?
|
Human Growth Hormone | 12 | 2016 | 683 | 1.480 |
Why?
|
Brain Neoplasms | 70 | 2017 | 8861 | 1.480 |
Why?
|
Intraoperative Complications | 11 | 2019 | 1198 | 1.310 |
Why?
|
Dopamine Agonists | 8 | 2019 | 355 | 1.270 |
Why?
|
History, 20th Century | 38 | 2016 | 2740 | 1.210 |
Why?
|
Arachnoid Cysts | 6 | 2019 | 59 | 1.200 |
Why?
|
Stereotaxic Techniques | 14 | 2007 | 536 | 1.190 |
Why?
|
Hydrocortisone | 16 | 2023 | 1826 | 1.170 |
Why?
|
Cysts | 6 | 2021 | 678 | 1.170 |
Why?
|
Hypopituitarism | 20 | 2018 | 254 | 1.150 |
Why?
|
Humans | 537 | 2024 | 744366 | 1.120 |
Why?
|
Neuronavigation | 3 | 2016 | 167 | 1.090 |
Why?
|
Preoperative Care | 12 | 2020 | 2251 | 1.060 |
Why?
|
Ki-67 Antigen | 10 | 2016 | 644 | 1.030 |
Why?
|
Surgery, Computer-Assisted | 6 | 2016 | 1018 | 1.030 |
Why?
|
Headache | 5 | 2017 | 1226 | 1.000 |
Why?
|
Endocrine Surgical Procedures | 4 | 2015 | 33 | 0.970 |
Why?
|
Magnetic Resonance Imaging | 71 | 2023 | 35425 | 0.960 |
Why?
|
Chordoma | 11 | 2017 | 359 | 0.950 |
Why?
|
Craniotomy | 19 | 2010 | 729 | 0.940 |
Why?
|
Adrenocorticotropic Hormone | 23 | 2021 | 648 | 0.930 |
Why?
|
Glioma | 30 | 2013 | 3401 | 0.930 |
Why?
|
Adult | 253 | 2021 | 214052 | 0.900 |
Why?
|
History, 19th Century | 20 | 2015 | 720 | 0.900 |
Why?
|
Astrocytoma | 24 | 2005 | 790 | 0.890 |
Why?
|
Cerebrospinal Fluid Shunts | 14 | 2016 | 189 | 0.870 |
Why?
|
Retrospective Studies | 90 | 2024 | 77460 | 0.860 |
Why?
|
Male | 285 | 2024 | 350115 | 0.860 |
Why?
|
Neoplasm Recurrence, Local | 38 | 2024 | 9240 | 0.850 |
Why?
|
Prolactin | 34 | 2016 | 669 | 0.850 |
Why?
|
Female | 295 | 2024 | 380193 | 0.850 |
Why?
|
Neoplasm Invasiveness | 19 | 2016 | 3616 | 0.840 |
Why?
|
Triiodothyronine | 4 | 2017 | 494 | 0.840 |
Why?
|
Hyperprolactinemia | 5 | 2016 | 129 | 0.840 |
Why?
|
Natural Orifice Endoscopic Surgery | 3 | 2019 | 118 | 0.840 |
Why?
|
Middle Aged | 214 | 2021 | 213390 | 0.820 |
Why?
|
Treatment Outcome | 84 | 2024 | 63107 | 0.810 |
Why?
|
Skull Neoplasms | 5 | 2013 | 173 | 0.780 |
Why?
|
Dermoid Cyst | 3 | 2016 | 93 | 0.750 |
Why?
|
Inappropriate ADH Syndrome | 4 | 2018 | 61 | 0.730 |
Why?
|
Cavernous Sinus | 6 | 2016 | 125 | 0.710 |
Why?
|
Adenoma, Oxyphilic | 2 | 2018 | 143 | 0.710 |
Why?
|
Diabetes Insipidus | 10 | 2015 | 151 | 0.700 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 4 | 2016 | 45 | 0.680 |
Why?
|
Postoperative Care | 10 | 2020 | 1487 | 0.680 |
Why?
|
Encephalocele | 2 | 2015 | 136 | 0.670 |
Why?
|
Brain Abscess | 2 | 2018 | 118 | 0.650 |
Why?
|
Intraoperative Care | 3 | 2020 | 767 | 0.630 |
Why?
|
Dura Mater | 5 | 2012 | 291 | 0.630 |
Why?
|
Meningeal Neoplasms | 9 | 2021 | 1241 | 0.620 |
Why?
|
Aged | 151 | 2021 | 163288 | 0.620 |
Why?
|
Psychosurgery | 4 | 2015 | 87 | 0.610 |
Why?
|
Abdominal Fat | 1 | 2019 | 223 | 0.600 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.580 |
Why?
|
Follow-Up Studies | 62 | 2022 | 39052 | 0.580 |
Why?
|
Hyponatremia | 4 | 2018 | 298 | 0.570 |
Why?
|
Drinking | 1 | 2018 | 197 | 0.570 |
Why?
|
Adolescent | 122 | 2021 | 85779 | 0.570 |
Why?
|
Pituitary Function Tests | 7 | 2015 | 27 | 0.570 |
Why?
|
Vision Disorders | 16 | 2019 | 1058 | 0.540 |
Why?
|
American Civil War | 1 | 2015 | 8 | 0.540 |
Why?
|
Meningocele | 1 | 2015 | 45 | 0.530 |
Why?
|
Drainage | 2 | 2018 | 1142 | 0.520 |
Why?
|
Meningitis, Pneumococcal | 1 | 2015 | 42 | 0.510 |
Why?
|
Reoperation | 14 | 2017 | 4201 | 0.500 |
Why?
|
Hemostasis, Surgical | 3 | 2002 | 128 | 0.500 |
Why?
|
Diskectomy | 2 | 2015 | 206 | 0.500 |
Why?
|
Meningioma | 12 | 2010 | 1209 | 0.500 |
Why?
|
Meningoencephalitis | 1 | 2015 | 78 | 0.500 |
Why?
|
Imaging, Three-Dimensional | 4 | 2016 | 4042 | 0.490 |
Why?
|
Baseball | 1 | 2015 | 90 | 0.480 |
Why?
|
Health Priorities | 1 | 2017 | 380 | 0.480 |
Why?
|
Monitoring, Intraoperative | 4 | 2016 | 957 | 0.480 |
Why?
|
Head Protective Devices | 1 | 2015 | 114 | 0.480 |
Why?
|
Liability, Legal | 1 | 2015 | 213 | 0.480 |
Why?
|
Surgical Wound Infection | 5 | 2019 | 1540 | 0.470 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2008 | 638 | 0.470 |
Why?
|
Epistaxis | 1 | 2014 | 111 | 0.470 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2016 | 1018 | 0.470 |
Why?
|
Thyrotropin | 10 | 2016 | 849 | 0.470 |
Why?
|
Hormone Replacement Therapy | 3 | 2016 | 745 | 0.460 |
Why?
|
Health Care Sector | 1 | 2015 | 194 | 0.460 |
Why?
|
Remission Induction | 15 | 2021 | 2385 | 0.450 |
Why?
|
Patient Readmission | 3 | 2018 | 3116 | 0.450 |
Why?
|
Thyroid Diseases | 1 | 2016 | 379 | 0.440 |
Why?
|
Adipose Tissue | 2 | 2016 | 3280 | 0.430 |
Why?
|
Checklist | 4 | 2016 | 833 | 0.430 |
Why?
|
Nose | 7 | 2021 | 509 | 0.430 |
Why?
|
Societies, Medical | 6 | 2017 | 3743 | 0.430 |
Why?
|
Carotid Artery, Internal | 2 | 2014 | 445 | 0.420 |
Why?
|
Brain Injuries | 5 | 2015 | 2029 | 0.400 |
Why?
|
Pregnancy Complications, Neoplastic | 2 | 2011 | 255 | 0.400 |
Why?
|
Methionine | 1 | 2014 | 590 | 0.400 |
Why?
|
Postoperative Period | 10 | 2022 | 1842 | 0.400 |
Why?
|
Octreotide | 2 | 2005 | 145 | 0.390 |
Why?
|
Malpractice | 2 | 2015 | 572 | 0.390 |
Why?
|
Growth Hormone | 20 | 2004 | 705 | 0.380 |
Why?
|
Laser Therapy | 4 | 2011 | 1072 | 0.380 |
Why?
|
Military Medicine | 2 | 2010 | 176 | 0.380 |
Why?
|
Specialties, Surgical | 1 | 2015 | 391 | 0.370 |
Why?
|
Lasers, Gas | 1 | 2011 | 93 | 0.370 |
Why?
|
Indocyanine Green | 1 | 2012 | 239 | 0.360 |
Why?
|
Psychophysiology | 1 | 2010 | 135 | 0.360 |
Why?
|
Hospitals, University | 1 | 2011 | 570 | 0.350 |
Why?
|
Intracranial Aneurysm | 7 | 2016 | 1197 | 0.350 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 714 | 0.350 |
Why?
|
Nelson Syndrome | 2 | 2007 | 20 | 0.350 |
Why?
|
Neoplasm, Residual | 6 | 2016 | 973 | 0.350 |
Why?
|
Child | 77 | 2021 | 77709 | 0.340 |
Why?
|
Glioblastoma | 11 | 2011 | 3481 | 0.340 |
Why?
|
Wounds and Injuries | 2 | 2015 | 2400 | 0.340 |
Why?
|
Paraneoplastic Endocrine Syndromes | 4 | 1996 | 31 | 0.330 |
Why?
|
Electrocoagulation | 3 | 2000 | 158 | 0.330 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2013 | 2016 | 0.320 |
Why?
|
Diagnosis, Differential | 24 | 2017 | 12961 | 0.320 |
Why?
|
Young Adult | 22 | 2018 | 56429 | 0.320 |
Why?
|
Case Management | 1 | 2010 | 286 | 0.320 |
Why?
|
Surgical Flaps | 2 | 2016 | 1640 | 0.310 |
Why?
|
Aged, 80 and over | 35 | 2020 | 57776 | 0.310 |
Why?
|
Ergolines | 3 | 2005 | 61 | 0.310 |
Why?
|
Transplantation, Autologous | 1 | 2012 | 2124 | 0.300 |
Why?
|
Recurrence | 11 | 2023 | 8340 | 0.300 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 233 | 0.290 |
Why?
|
Prognosis | 32 | 2021 | 29060 | 0.290 |
Why?
|
Karnofsky Performance Status | 3 | 2010 | 173 | 0.290 |
Why?
|
Carcinoma | 5 | 2011 | 2375 | 0.290 |
Why?
|
Music | 1 | 2010 | 263 | 0.290 |
Why?
|
Receptors, Estrogen | 5 | 1999 | 2190 | 0.280 |
Why?
|
Vascular Surgical Procedures | 3 | 2007 | 1476 | 0.280 |
Why?
|
Neuroanatomy | 1 | 2006 | 66 | 0.280 |
Why?
|
Antidiuretic Agents | 1 | 2006 | 24 | 0.280 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2006 | 19 | 0.280 |
Why?
|
Rhizotomy | 2 | 2005 | 30 | 0.270 |
Why?
|
Bone Substitutes | 1 | 2008 | 229 | 0.270 |
Why?
|
Health Care Reform | 1 | 2015 | 1261 | 0.270 |
Why?
|
Central Nervous System Neoplasms | 4 | 2005 | 895 | 0.270 |
Why?
|
Vascular Diseases | 4 | 2006 | 1161 | 0.270 |
Why?
|
Combined Modality Therapy | 22 | 2020 | 8642 | 0.260 |
Why?
|
Hypothalamus | 4 | 2010 | 1063 | 0.260 |
Why?
|
Radiotherapy, Adjuvant | 9 | 2020 | 1771 | 0.260 |
Why?
|
Carmustine | 3 | 2003 | 137 | 0.260 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1209 | 0.260 |
Why?
|
Treatment Failure | 7 | 2018 | 2618 | 0.260 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1438 | 0.260 |
Why?
|
Retreatment | 2 | 2024 | 610 | 0.250 |
Why?
|
Somatostatin | 4 | 2005 | 459 | 0.250 |
Why?
|
Cerebral Arteries | 2 | 1998 | 494 | 0.250 |
Why?
|
Infarction | 1 | 2006 | 244 | 0.250 |
Why?
|
Spinal Nerve Roots | 1 | 2005 | 121 | 0.250 |
Why?
|
United States | 33 | 2021 | 69872 | 0.250 |
Why?
|
Ultrasonography, Doppler | 2 | 2016 | 458 | 0.240 |
Why?
|
Cranial Fossa, Posterior | 3 | 2000 | 139 | 0.240 |
Why?
|
General Surgery | 3 | 2005 | 1636 | 0.240 |
Why?
|
Adenoma, Basophil | 1 | 2003 | 1 | 0.240 |
Why?
|
Brain Concussion | 1 | 2015 | 1320 | 0.240 |
Why?
|
Blood Loss, Surgical | 3 | 2005 | 662 | 0.240 |
Why?
|
Specialization | 2 | 2007 | 776 | 0.240 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2645 | 0.240 |
Why?
|
Perioperative Care | 3 | 2012 | 1002 | 0.230 |
Why?
|
Hypothalamic Diseases | 1 | 2005 | 135 | 0.230 |
Why?
|
Bromocriptine | 9 | 2005 | 111 | 0.230 |
Why?
|
Cerebral Angiography | 7 | 2016 | 1285 | 0.230 |
Why?
|
Drug Implants | 2 | 2003 | 244 | 0.230 |
Why?
|
Cerebral Palsy | 2 | 2005 | 459 | 0.230 |
Why?
|
Hydrocephalus | 9 | 2012 | 748 | 0.230 |
Why?
|
Time Factors | 24 | 2018 | 40075 | 0.220 |
Why?
|
History, 21st Century | 3 | 2016 | 1534 | 0.220 |
Why?
|
Adrenal Glands | 1 | 2005 | 546 | 0.220 |
Why?
|
Drug Therapy | 1 | 2006 | 497 | 0.220 |
Why?
|
Cell Transformation, Neoplastic | 6 | 2006 | 2943 | 0.220 |
Why?
|
Famous Persons | 2 | 2015 | 108 | 0.210 |
Why?
|
Thalamus | 3 | 1999 | 1023 | 0.210 |
Why?
|
Gelatin Sponge, Absorbable | 1 | 2002 | 60 | 0.210 |
Why?
|
Epilepsy, Temporal Lobe | 5 | 1997 | 403 | 0.210 |
Why?
|
Incidence | 9 | 2016 | 20952 | 0.210 |
Why?
|
Craniocerebral Trauma | 6 | 2010 | 482 | 0.210 |
Why?
|
Globus Pallidus | 3 | 1999 | 253 | 0.210 |
Why?
|
Immunohistochemistry | 18 | 2016 | 11366 | 0.210 |
Why?
|
Neurilemmoma | 4 | 2003 | 547 | 0.210 |
Why?
|
World Health Organization | 4 | 2021 | 1318 | 0.200 |
Why?
|
Adrenocortical Hyperfunction | 1 | 2001 | 14 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 38 | 2015 | 20130 | 0.200 |
Why?
|
Brain | 13 | 2010 | 26388 | 0.200 |
Why?
|
Follicle Stimulating Hormone | 6 | 2016 | 744 | 0.200 |
Why?
|
Fluoroscopy | 2 | 2006 | 924 | 0.190 |
Why?
|
Pituitary Irradiation | 1 | 2000 | 17 | 0.190 |
Why?
|
Carcinoma, Small Cell | 2 | 1999 | 420 | 0.190 |
Why?
|
Ganglioglioma | 1 | 2001 | 42 | 0.190 |
Why?
|
Therapy, Computer-Assisted | 2 | 2001 | 271 | 0.190 |
Why?
|
Neoplasm Transplantation | 7 | 1993 | 2086 | 0.190 |
Why?
|
Body Constitution | 1 | 2021 | 278 | 0.190 |
Why?
|
Galactorrhea | 7 | 2016 | 24 | 0.180 |
Why?
|
Brain Diseases | 5 | 1995 | 1563 | 0.180 |
Why?
|
Patient Selection | 3 | 2010 | 4216 | 0.180 |
Why?
|
Medicine | 2 | 2007 | 946 | 0.180 |
Why?
|
Neoplasm Metastasis | 6 | 2006 | 4851 | 0.180 |
Why?
|
Lip | 2 | 2002 | 195 | 0.180 |
Why?
|
Gait | 2 | 2005 | 793 | 0.180 |
Why?
|
Peripheral Nerves | 1 | 2003 | 466 | 0.170 |
Why?
|
Granular Cell Tumor | 1 | 2019 | 51 | 0.170 |
Why?
|
Databases, Factual | 7 | 2021 | 7730 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2016 | 8949 | 0.170 |
Why?
|
Temporal Lobe | 5 | 2002 | 1670 | 0.170 |
Why?
|
Disease Management | 4 | 2020 | 2460 | 0.170 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2003 | 627 | 0.170 |
Why?
|
Microscopy, Electron | 10 | 2000 | 2646 | 0.170 |
Why?
|
Growth Disorders | 2 | 2005 | 645 | 0.170 |
Why?
|
Neurology | 1 | 2007 | 763 | 0.170 |
Why?
|
Child, Preschool | 32 | 2018 | 41005 | 0.170 |
Why?
|
Growth Hormone-Releasing Hormone | 3 | 1997 | 213 | 0.170 |
Why?
|
Hematoma, Epidural, Cranial | 1 | 1999 | 60 | 0.170 |
Why?
|
Dissection | 2 | 2010 | 295 | 0.160 |
Why?
|
Cell Division | 5 | 1999 | 4569 | 0.160 |
Why?
|
Equipment Design | 7 | 2015 | 3582 | 0.160 |
Why?
|
Periodicals as Topic | 3 | 2008 | 1431 | 0.160 |
Why?
|
Electrodes, Implanted | 2 | 2007 | 824 | 0.160 |
Why?
|
Absorbable Implants | 1 | 2001 | 342 | 0.160 |
Why?
|
Computer Systems | 2 | 2015 | 483 | 0.160 |
Why?
|
Immunoenzyme Techniques | 10 | 1996 | 1799 | 0.160 |
Why?
|
Neoplasms, Radiation-Induced | 3 | 2005 | 547 | 0.160 |
Why?
|
Survival Rate | 12 | 2017 | 12788 | 0.160 |
Why?
|
Radiography | 12 | 2011 | 7023 | 0.150 |
Why?
|
Health Services | 2 | 2013 | 758 | 0.150 |
Why?
|
Reflex, Babinski | 1 | 1997 | 7 | 0.150 |
Why?
|
Hematoporphyrin Photoradiation | 2 | 1987 | 17 | 0.150 |
Why?
|
Physician's Role | 1 | 2004 | 943 | 0.150 |
Why?
|
Paresthesia | 2 | 2003 | 161 | 0.150 |
Why?
|
Cerebral Ventriculography | 3 | 2013 | 44 | 0.150 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5321 | 0.150 |
Why?
|
Basal Ganglia | 2 | 1999 | 546 | 0.150 |
Why?
|
Cerebellar Neoplasms | 6 | 1999 | 587 | 0.150 |
Why?
|
Cohort Studies | 11 | 2023 | 40559 | 0.150 |
Why?
|
Spinal Neoplasms | 2 | 1995 | 760 | 0.150 |
Why?
|
Antibodies, Antinuclear | 2 | 2010 | 326 | 0.150 |
Why?
|
Hypothalamic Neoplasms | 3 | 2006 | 22 | 0.140 |
Why?
|
Neuroma, Acoustic | 6 | 1985 | 451 | 0.140 |
Why?
|
Skull | 3 | 2011 | 814 | 0.140 |
Why?
|
Methods | 15 | 1990 | 1129 | 0.140 |
Why?
|
Bone Cements | 1 | 2018 | 325 | 0.140 |
Why?
|
Benchmarking | 2 | 2016 | 1042 | 0.140 |
Why?
|
Surgical Instruments | 5 | 2010 | 395 | 0.140 |
Why?
|
Incisor | 1 | 1997 | 179 | 0.140 |
Why?
|
Austria | 3 | 2006 | 202 | 0.140 |
Why?
|
Hypothyroidism | 4 | 2006 | 658 | 0.140 |
Why?
|
Glucocorticoids | 3 | 2012 | 2108 | 0.140 |
Why?
|
Neurophysiology | 1 | 1997 | 142 | 0.140 |
Why?
|
Adrenalectomy | 2 | 2009 | 341 | 0.140 |
Why?
|
Fibrosarcoma | 1 | 1998 | 348 | 0.140 |
Why?
|
Pituitary Gland, Anterior | 8 | 1998 | 177 | 0.140 |
Why?
|
Neurosciences | 1 | 2000 | 348 | 0.140 |
Why?
|
Aneurysm, False | 2 | 2014 | 276 | 0.140 |
Why?
|
Cranial Nerves | 1 | 2016 | 101 | 0.130 |
Why?
|
Length of Stay | 4 | 2018 | 6311 | 0.130 |
Why?
|
Hemangioblastoma | 1 | 1996 | 70 | 0.130 |
Why?
|
Risk Factors | 15 | 2022 | 72296 | 0.130 |
Why?
|
Hemorrhage | 2 | 2015 | 3461 | 0.130 |
Why?
|
Cerebral Veins | 1 | 1997 | 156 | 0.130 |
Why?
|
Defensive Medicine | 1 | 2015 | 48 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6539 | 0.130 |
Why?
|
Antineoplastic Agents | 6 | 2010 | 13693 | 0.130 |
Why?
|
Obesity | 3 | 2022 | 12746 | 0.130 |
Why?
|
Nasal Septum | 4 | 1992 | 127 | 0.130 |
Why?
|
Biopsy | 6 | 2011 | 6755 | 0.130 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 501 | 0.130 |
Why?
|
Prevalence | 6 | 2017 | 15221 | 0.130 |
Why?
|
Calcium Pyrophosphate | 1 | 1995 | 49 | 0.130 |
Why?
|
Ploidies | 2 | 2006 | 281 | 0.130 |
Why?
|
Head Injuries, Penetrating | 1 | 2015 | 28 | 0.130 |
Why?
|
Chondroma | 1 | 1995 | 58 | 0.130 |
Why?
|
Equipment Safety | 1 | 2016 | 263 | 0.130 |
Why?
|
Arginine Vasopressin | 1 | 2015 | 130 | 0.130 |
Why?
|
Electrosurgery | 2 | 2005 | 58 | 0.130 |
Why?
|
Hematoporphyrins | 3 | 1986 | 23 | 0.130 |
Why?
|
Central Nervous System Diseases | 1 | 1999 | 518 | 0.130 |
Why?
|
Academic Medical Centers | 1 | 2005 | 2760 | 0.130 |
Why?
|
Angiography, Digital Subtraction | 1 | 2016 | 341 | 0.130 |
Why?
|
Cerebral Hemorrhage | 6 | 2012 | 2647 | 0.130 |
Why?
|
Nose Neoplasms | 4 | 1998 | 246 | 0.120 |
Why?
|
Endocrinology | 3 | 2014 | 443 | 0.120 |
Why?
|
Peer Review, Research | 1 | 1997 | 329 | 0.120 |
Why?
|
Hydrocephalus, Normal Pressure | 4 | 1987 | 92 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2016 | 457 | 0.120 |
Why?
|
Intracranial Hemorrhages | 3 | 2015 | 855 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2007 | 3480 | 0.120 |
Why?
|
Tumor Burden | 2 | 2010 | 1915 | 0.120 |
Why?
|
Petrosal Sinus Sampling | 2 | 2007 | 23 | 0.120 |
Why?
|
Testosterone | 3 | 2010 | 2419 | 0.120 |
Why?
|
Abducens Nerve | 1 | 1993 | 28 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2017 | 8432 | 0.120 |
Why?
|
Intraoperative Period | 2 | 2010 | 520 | 0.120 |
Why?
|
Logistic Models | 4 | 2017 | 13409 | 0.120 |
Why?
|
Inflammation | 3 | 2015 | 10637 | 0.120 |
Why?
|
Anemia | 1 | 2003 | 1503 | 0.110 |
Why?
|
Accessory Nerve | 1 | 1993 | 11 | 0.110 |
Why?
|
Anesthetics, Intravenous | 1 | 2017 | 417 | 0.110 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 504 | 0.110 |
Why?
|
Twins, Monozygotic | 1 | 2015 | 458 | 0.110 |
Why?
|
RNA, Messenger | 11 | 2016 | 13035 | 0.110 |
Why?
|
Historiography | 1 | 1993 | 8 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1071 | 0.110 |
Why?
|
Nervous System Malformations | 1 | 2015 | 247 | 0.110 |
Why?
|
Foundations | 1 | 1993 | 94 | 0.110 |
Why?
|
Quality of Life | 7 | 2016 | 12802 | 0.110 |
Why?
|
Cerebrospinal Fluid Otorrhea | 2 | 2002 | 15 | 0.110 |
Why?
|
Abdomen | 1 | 2019 | 1118 | 0.110 |
Why?
|
Atrophy | 3 | 2007 | 1584 | 0.110 |
Why?
|
Thyroxine | 1 | 2016 | 667 | 0.110 |
Why?
|
Prospective Studies | 12 | 2022 | 53290 | 0.110 |
Why?
|
Epilepsies, Partial | 3 | 1988 | 436 | 0.110 |
Why?
|
Demyelinating Diseases | 1 | 1995 | 354 | 0.110 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 1999 | 1524 | 0.110 |
Why?
|
Lactotrophs | 1 | 2012 | 3 | 0.110 |
Why?
|
SEER Program | 1 | 2017 | 1507 | 0.110 |
Why?
|
Homicide | 1 | 2015 | 287 | 0.110 |
Why?
|
Rats | 14 | 2012 | 24252 | 0.110 |
Why?
|
Lumbar Vertebrae | 2 | 2018 | 1848 | 0.110 |
Why?
|
Medulloblastoma | 4 | 1999 | 683 | 0.110 |
Why?
|
Cognition Disorders | 1 | 2007 | 4043 | 0.100 |
Why?
|
Photochemotherapy | 3 | 1987 | 807 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2006 | 2949 | 0.100 |
Why?
|
Facial Nerve | 2 | 1993 | 271 | 0.100 |
Why?
|
Paralysis | 1 | 1993 | 247 | 0.100 |
Why?
|
DNA Copy Number Variations | 2 | 2017 | 1941 | 0.100 |
Why?
|
Neoplasm Proteins | 4 | 2015 | 3707 | 0.100 |
Why?
|
Laminectomy | 3 | 2005 | 234 | 0.100 |
Why?
|
Hemostasis | 1 | 2014 | 458 | 0.100 |
Why?
|
Supratentorial Neoplasms | 2 | 1990 | 160 | 0.100 |
Why?
|
Cerebral Ventricles | 3 | 1989 | 544 | 0.100 |
Why?
|
History, 18th Century | 3 | 2007 | 213 | 0.100 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 2 | 1994 | 98 | 0.100 |
Why?
|
Gene Expression | 4 | 2016 | 7798 | 0.100 |
Why?
|
Thyroid Gland | 2 | 2017 | 1173 | 0.100 |
Why?
|
Virginia | 3 | 2007 | 121 | 0.100 |
Why?
|
Blood Vessels | 3 | 2016 | 1125 | 0.100 |
Why?
|
Argentina | 1 | 2011 | 232 | 0.100 |
Why?
|
Radiotherapy Dosage | 6 | 2007 | 2879 | 0.100 |
Why?
|
Statistics as Topic | 1 | 2017 | 2373 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2017 | 594 | 0.100 |
Why?
|
Contractile Proteins | 1 | 2012 | 246 | 0.090 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12244 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 838 | 0.090 |
Why?
|
Patient Care Team | 3 | 2015 | 2531 | 0.090 |
Why?
|
Animals | 23 | 2018 | 168768 | 0.090 |
Why?
|
Seizures | 4 | 2016 | 2859 | 0.090 |
Why?
|
Pitch Discrimination | 1 | 2010 | 39 | 0.090 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2010 | 85 | 0.090 |
Why?
|
Tumor Cells, Cultured | 5 | 2012 | 6313 | 0.090 |
Why?
|
Histocytochemistry | 4 | 2007 | 719 | 0.090 |
Why?
|
Vasospasm, Intracranial | 1 | 2012 | 208 | 0.090 |
Why?
|
Sex Factors | 13 | 2014 | 10400 | 0.090 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15078 | 0.090 |
Why?
|
Deamino Arginine Vasopressin | 2 | 2010 | 91 | 0.090 |
Why?
|
Vietnam Conflict | 1 | 2010 | 99 | 0.090 |
Why?
|
Risk | 6 | 2016 | 9688 | 0.090 |
Why?
|
Syndrome | 1 | 2016 | 3252 | 0.090 |
Why?
|
Pregnancy | 12 | 2016 | 29144 | 0.090 |
Why?
|
COUP Transcription Factor I | 1 | 2009 | 12 | 0.090 |
Why?
|
Databases as Topic | 2 | 2005 | 475 | 0.090 |
Why?
|
Social Support | 1 | 2019 | 2118 | 0.090 |
Why?
|
Pathology, Surgical | 1 | 2011 | 155 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 2031 | 0.090 |
Why?
|
Epidermal Cyst | 1 | 2010 | 62 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2013 | 1590 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2016 | 828 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 693 | 0.090 |
Why?
|
Wounds, Penetrating | 2 | 2010 | 307 | 0.090 |
Why?
|
Boxing | 1 | 2009 | 15 | 0.090 |
Why?
|
Receptors, Dopamine D2 | 1 | 2012 | 475 | 0.090 |
Why?
|
Fluorescence | 1 | 2012 | 751 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 1572 | 0.090 |
Why?
|
Psychomotor Agitation | 1 | 2011 | 293 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2204 | 0.090 |
Why?
|
Wounds, Gunshot | 1 | 2015 | 563 | 0.090 |
Why?
|
Pseudotumor Cerebri | 1 | 2010 | 100 | 0.080 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2010 | 67 | 0.080 |
Why?
|
Sarcoma | 1 | 2020 | 1897 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1525 | 0.080 |
Why?
|
Radiation-Sensitizing Agents | 2 | 1998 | 358 | 0.080 |
Why?
|
Ventriculostomy | 1 | 2010 | 136 | 0.080 |
Why?
|
France | 2 | 2003 | 517 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.080 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 2 | 2006 | 65 | 0.080 |
Why?
|
Neoplasms, Nerve Tissue | 1 | 1988 | 23 | 0.080 |
Why?
|
Clinical Protocols | 2 | 2012 | 1461 | 0.080 |
Why?
|
Reflex, Stretch | 2 | 2005 | 23 | 0.080 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12356 | 0.080 |
Why?
|
Piperidines | 1 | 2017 | 1602 | 0.080 |
Why?
|
Spasm | 2 | 1986 | 121 | 0.080 |
Why?
|
Calcinosis | 2 | 1995 | 1499 | 0.080 |
Why?
|
Guideline Adherence | 2 | 2016 | 2265 | 0.080 |
Why?
|
Workers' Compensation | 2 | 1999 | 152 | 0.080 |
Why?
|
Receptors, Somatotropin | 2 | 2005 | 76 | 0.080 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 1998 | 1391 | 0.080 |
Why?
|
Arachnoid | 1 | 1987 | 48 | 0.080 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2002 | 604 | 0.080 |
Why?
|
Interprofessional Relations | 2 | 2005 | 1011 | 0.080 |
Why?
|
Education, Medical, Graduate | 2 | 2005 | 2291 | 0.080 |
Why?
|
Adenoma, Chromophobe | 4 | 1983 | 16 | 0.080 |
Why?
|
Radiotherapy | 4 | 2008 | 1533 | 0.080 |
Why?
|
Forecasting | 3 | 2005 | 2951 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 4751 | 0.080 |
Why?
|
History, Ancient | 1 | 2008 | 212 | 0.080 |
Why?
|
Emergency Service, Hospital | 1 | 2007 | 7658 | 0.080 |
Why?
|
Soccer | 1 | 2009 | 133 | 0.080 |
Why?
|
Anticoagulants | 4 | 2015 | 4600 | 0.070 |
Why?
|
Amenorrhea | 5 | 2005 | 485 | 0.070 |
Why?
|
Signal Transduction | 2 | 2012 | 23404 | 0.070 |
Why?
|
Visual Fields | 6 | 2016 | 1047 | 0.070 |
Why?
|
Chi-Square Distribution | 4 | 2017 | 3508 | 0.070 |
Why?
|
Dacarbazine | 1 | 2010 | 566 | 0.070 |
Why?
|
Hirsutism | 2 | 2005 | 69 | 0.070 |
Why?
|
Pyrones | 1 | 2007 | 36 | 0.070 |
Why?
|
Anesthesia | 4 | 2015 | 1561 | 0.070 |
Why?
|
Luteinizing Hormone | 5 | 1998 | 869 | 0.070 |
Why?
|
Geologic Sediments | 1 | 2007 | 77 | 0.070 |
Why?
|
Rats, Inbred Strains | 7 | 1992 | 2186 | 0.070 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13991 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 1986 | 3759 | 0.070 |
Why?
|
Reference Values | 4 | 2011 | 4982 | 0.070 |
Why?
|
Internship and Residency | 2 | 2012 | 5791 | 0.070 |
Why?
|
Necrosis | 2 | 2015 | 1643 | 0.070 |
Why?
|
International Cooperation | 1 | 1993 | 1420 | 0.070 |
Why?
|
Hemangioma, Cavernous | 1 | 1987 | 110 | 0.070 |
Why?
|
Dexamethasone | 3 | 2012 | 1951 | 0.070 |
Why?
|
Water Microbiology | 1 | 2007 | 117 | 0.070 |
Why?
|
Pineal Gland | 2 | 1985 | 166 | 0.070 |
Why?
|
Glial Fibrillary Acidic Protein | 4 | 1994 | 529 | 0.070 |
Why?
|
Pergolide | 2 | 2005 | 3 | 0.070 |
Why?
|
Lymphocytes, Null | 1 | 2005 | 13 | 0.070 |
Why?
|
Facial Nerve Diseases | 1 | 1986 | 50 | 0.070 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1152 | 0.070 |
Why?
|
Pinealoma | 3 | 1985 | 54 | 0.070 |
Why?
|
Arnold-Chiari Malformation | 1 | 1988 | 154 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3229 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2926 | 0.070 |
Why?
|
Risk Assessment | 1 | 2007 | 23336 | 0.070 |
Why?
|
Meningitis, Bacterial | 2 | 2001 | 218 | 0.070 |
Why?
|
Subdural Effusion | 1 | 2005 | 19 | 0.070 |
Why?
|
Pituitary Gland, Posterior | 1 | 2005 | 43 | 0.070 |
Why?
|
Disease-Free Survival | 4 | 2015 | 6896 | 0.070 |
Why?
|
Embolization, Therapeutic | 2 | 2014 | 1392 | 0.070 |
Why?
|
International Educational Exchange | 1 | 2005 | 50 | 0.070 |
Why?
|
Glycoproteins | 3 | 2011 | 2266 | 0.070 |
Why?
|
Hormones, Ectopic | 3 | 1994 | 40 | 0.070 |
Why?
|
Review Literature as Topic | 1 | 2008 | 336 | 0.070 |
Why?
|
Choristoma | 2 | 1986 | 214 | 0.070 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2007 | 821 | 0.070 |
Why?
|
Blotting, Western | 2 | 2008 | 5181 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 1995 | 1363 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2212 | 0.070 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2006 | 285 | 0.070 |
Why?
|
Facial Muscles | 1 | 1986 | 157 | 0.070 |
Why?
|
Cerebral Infarction | 2 | 2008 | 1011 | 0.070 |
Why?
|
Dominance, Cerebral | 2 | 2005 | 635 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 323 | 0.070 |
Why?
|
Cranial Fossa, Middle | 1 | 2005 | 28 | 0.070 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2010 | 632 | 0.070 |
Why?
|
Hamartoma | 2 | 1986 | 238 | 0.070 |
Why?
|
Hospitals | 2 | 2015 | 3954 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1988 | 730 | 0.070 |
Why?
|
Algorithms | 4 | 2006 | 13882 | 0.060 |
Why?
|
Health Status | 2 | 2017 | 4034 | 0.060 |
Why?
|
Eye Neoplasms | 1 | 1987 | 312 | 0.060 |
Why?
|
Rats, Zucker | 1 | 2005 | 128 | 0.060 |
Why?
|
Carotid Arteries | 2 | 2009 | 950 | 0.060 |
Why?
|
Correspondence as Topic | 1 | 2005 | 27 | 0.060 |
Why?
|
Actuarial Analysis | 1 | 2005 | 378 | 0.060 |
Why?
|
Chicago | 1 | 2005 | 240 | 0.060 |
Why?
|
Basilar Artery | 1 | 2006 | 200 | 0.060 |
Why?
|
Putamen | 1 | 2006 | 291 | 0.060 |
Why?
|
Trigeminal Neuralgia | 1 | 1986 | 113 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2017 | 1620 | 0.060 |
Why?
|
Meninges | 1 | 1986 | 190 | 0.060 |
Why?
|
Pituitary-Adrenal System | 3 | 2002 | 553 | 0.060 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 3841 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7282 | 0.060 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2005 | 113 | 0.060 |
Why?
|
Protoporphyrins | 1 | 2005 | 164 | 0.060 |
Why?
|
Parkinson Disease | 3 | 2006 | 2775 | 0.060 |
Why?
|
Cell Proliferation | 4 | 2012 | 10483 | 0.060 |
Why?
|
Hippocampus | 1 | 1997 | 3675 | 0.060 |
Why?
|
Hemangiopericytoma | 2 | 2002 | 77 | 0.060 |
Why?
|
In Situ Hybridization | 3 | 1999 | 1950 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 1996 | 5856 | 0.060 |
Why?
|
Fluorescent Dyes | 1 | 2012 | 1917 | 0.060 |
Why?
|
Hyperpituitarism | 1 | 2003 | 2 | 0.060 |
Why?
|
Friends | 1 | 2005 | 154 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2043 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 3 | 1994 | 2505 | 0.060 |
Why?
|
Hyperthyroidism | 1 | 2006 | 295 | 0.060 |
Why?
|
Age Factors | 15 | 2014 | 18373 | 0.060 |
Why?
|
Phenotype | 2 | 2016 | 16367 | 0.060 |
Why?
|
Phytohemagglutinins | 3 | 1993 | 170 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2013 | 1580 | 0.060 |
Why?
|
Perception | 1 | 2010 | 1198 | 0.060 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2004 | 174 | 0.060 |
Why?
|
Electroencephalography | 6 | 2016 | 6151 | 0.060 |
Why?
|
Apolipoproteins E | 1 | 1989 | 1438 | 0.060 |
Why?
|
Carotid Artery Diseases | 3 | 1979 | 879 | 0.060 |
Why?
|
Premedication | 2 | 1998 | 258 | 0.060 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1995 | 2020 | 0.060 |
Why?
|
Electromyography | 2 | 2005 | 1379 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1376 | 0.050 |
Why?
|
Graves Disease | 1 | 2004 | 242 | 0.050 |
Why?
|
Hypogonadism | 3 | 2010 | 799 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3611 | 0.050 |
Why?
|
Gait Disorders, Neurologic | 1 | 2005 | 231 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9312 | 0.050 |
Why?
|
Critical Care | 1 | 2015 | 2647 | 0.050 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 312 | 0.050 |
Why?
|
Multiple Endocrine Neoplasia | 3 | 1987 | 25 | 0.050 |
Why?
|
Infant | 17 | 2014 | 35134 | 0.050 |
Why?
|
Uterine Neoplasms | 1 | 2011 | 1513 | 0.050 |
Why?
|
Complementary Therapies | 1 | 2006 | 486 | 0.050 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 1984 | 703 | 0.050 |
Why?
|
Contraceptives, Oral | 2 | 2022 | 564 | 0.050 |
Why?
|
Protein Kinase C | 1 | 2007 | 1227 | 0.050 |
Why?
|
Lung Neoplasms | 4 | 1999 | 13104 | 0.050 |
Why?
|
Surgical Equipment | 2 | 2012 | 57 | 0.050 |
Why?
|
Equipment Failure | 2 | 2012 | 578 | 0.050 |
Why?
|
Spinal Cord Diseases | 1 | 1985 | 298 | 0.050 |
Why?
|
Posture | 2 | 2005 | 958 | 0.050 |
Why?
|
Quality Improvement | 1 | 2017 | 3749 | 0.050 |
Why?
|
Hematocrit | 1 | 2003 | 636 | 0.050 |
Why?
|
Transplantation, Heterologous | 4 | 1993 | 2383 | 0.050 |
Why?
|
Acute Disease | 2 | 2007 | 7147 | 0.050 |
Why?
|
Clinical Competence | 2 | 2008 | 4687 | 0.050 |
Why?
|
Range of Motion, Articular | 2 | 2005 | 1578 | 0.050 |
Why?
|
Hypertension | 5 | 2015 | 8479 | 0.050 |
Why?
|
Advisory Committees | 1 | 2005 | 775 | 0.050 |
Why?
|
Hospitals, Military | 2 | 1999 | 67 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9274 | 0.050 |
Why?
|
Retinal Diseases | 1 | 1987 | 684 | 0.050 |
Why?
|
Disasters | 1 | 2007 | 511 | 0.050 |
Why?
|
Congresses as Topic | 1 | 2005 | 764 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2014 | 1980 | 0.050 |
Why?
|
Language | 1 | 2010 | 1471 | 0.050 |
Why?
|
Blood-Brain Barrier | 2 | 2002 | 1019 | 0.050 |
Why?
|
Anxiety | 2 | 2013 | 4293 | 0.050 |
Why?
|
Drug Design | 1 | 2006 | 1076 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2007 | 3702 | 0.050 |
Why?
|
Guidelines as Topic | 2 | 2012 | 1405 | 0.050 |
Why?
|
Neurologic Examination | 3 | 2000 | 931 | 0.050 |
Why?
|
Microscopy | 1 | 2005 | 902 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4026 | 0.050 |
Why?
|
Diploidy | 1 | 2000 | 138 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 1993 | 4554 | 0.050 |
Why?
|
Giant Cell Arteritis | 1 | 2004 | 292 | 0.050 |
Why?
|
Otolaryngology | 1 | 2007 | 645 | 0.050 |
Why?
|
Nervous System Diseases | 3 | 2012 | 1622 | 0.050 |
Why?
|
Evaluation Studies as Topic | 2 | 1999 | 1681 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2005 | 594 | 0.040 |
Why?
|
Vision, Ocular | 1 | 1983 | 464 | 0.040 |
Why?
|
Nerve Growth Factors | 1 | 2003 | 574 | 0.040 |
Why?
|
Atlanto-Occipital Joint | 1 | 1979 | 33 | 0.040 |
Why?
|
Spinal Cord | 1 | 1988 | 1810 | 0.040 |
Why?
|
Cerebral Cortex | 7 | 1991 | 5709 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2004 | 599 | 0.040 |
Why?
|
Drug Administration Schedule | 3 | 2003 | 4933 | 0.040 |
Why?
|
Minnesota | 7 | 1989 | 344 | 0.040 |
Why?
|
Circadian Rhythm | 2 | 2021 | 2624 | 0.040 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 1982 | 356 | 0.040 |
Why?
|
Luminescent Measurements | 1 | 2001 | 405 | 0.040 |
Why?
|
Diencephalon | 1 | 1999 | 56 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2015 | 19905 | 0.040 |
Why?
|
Hormones | 3 | 1988 | 889 | 0.040 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 1999 | 44 | 0.040 |
Why?
|
Steroids | 1 | 2004 | 930 | 0.040 |
Why?
|
Polyesters | 1 | 2001 | 363 | 0.040 |
Why?
|
Indoles | 1 | 1987 | 1839 | 0.040 |
Why?
|
Erythropoiesis | 1 | 2003 | 706 | 0.040 |
Why?
|
Estrogen Receptor Modulators | 1 | 1999 | 61 | 0.040 |
Why?
|
Carotid Artery Injuries | 1 | 1999 | 96 | 0.040 |
Why?
|
Cell Movement | 6 | 1994 | 5218 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4567 | 0.040 |
Why?
|
Drug Resistance | 1 | 2005 | 1608 | 0.040 |
Why?
|
Drug Carriers | 1 | 2003 | 693 | 0.040 |
Why?
|
Peptides | 1 | 2011 | 4410 | 0.040 |
Why?
|
Microscopy, Electron, Scanning | 4 | 1994 | 963 | 0.040 |
Why?
|
Lovastatin | 1 | 1998 | 120 | 0.040 |
Why?
|
Cerebellum | 3 | 1985 | 1488 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4222 | 0.040 |
Why?
|
Infant, Newborn | 6 | 2014 | 25628 | 0.040 |
Why?
|
Rhinoplasty | 2 | 1997 | 226 | 0.040 |
Why?
|
Data Display | 1 | 1999 | 182 | 0.040 |
Why?
|
Oligodendroglioma | 4 | 1989 | 279 | 0.040 |
Why?
|
Emotions | 1 | 2010 | 2659 | 0.040 |
Why?
|
Blotting, Northern | 2 | 1997 | 1581 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2015 | 7182 | 0.040 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 1998 | 56 | 0.040 |
Why?
|
Receptors, Drug | 1 | 1998 | 160 | 0.040 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 1980 | 234 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 25039 | 0.040 |
Why?
|
Levodopa | 1 | 1998 | 219 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 1998 | 175 | 0.040 |
Why?
|
Radiation Dosage | 4 | 2006 | 1928 | 0.040 |
Why?
|
Microelectrodes | 1 | 1999 | 303 | 0.040 |
Why?
|
Bone Plates | 1 | 2001 | 468 | 0.040 |
Why?
|
Receptors, Progesterone | 2 | 1994 | 1098 | 0.040 |
Why?
|
Pediatrics | 2 | 2005 | 3475 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2003 | 685 | 0.040 |
Why?
|
Eponyms | 1 | 1997 | 15 | 0.040 |
Why?
|
Antiparkinson Agents | 1 | 1998 | 184 | 0.040 |
Why?
|
Internet | 2 | 2014 | 3056 | 0.040 |
Why?
|
Occipital Bone | 1 | 1997 | 54 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3505 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 2 | 2012 | 639 | 0.040 |
Why?
|
Hyperplasia | 4 | 2011 | 1185 | 0.040 |
Why?
|
Facial Pain | 1 | 1998 | 127 | 0.040 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 1998 | 150 | 0.040 |
Why?
|
Ophthalmoplegia | 1 | 1998 | 166 | 0.040 |
Why?
|
Thrombosis | 2 | 1999 | 2968 | 0.040 |
Why?
|
Sulfurtransferases | 3 | 1985 | 17 | 0.040 |
Why?
|
Cell Nucleus | 3 | 1996 | 2969 | 0.040 |
Why?
|
Sclerosis | 1 | 1997 | 213 | 0.040 |
Why?
|
Cell Lineage | 1 | 2005 | 2504 | 0.040 |
Why?
|
Chromogranins | 1 | 2017 | 160 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2010 | 6171 | 0.040 |
Why?
|
Adrenal Insufficiency | 2 | 2013 | 184 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9981 | 0.040 |
Why?
|
Canada | 2 | 2015 | 2065 | 0.030 |
Why?
|
Cause of Death | 2 | 1999 | 3582 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2003 | 5077 | 0.030 |
Why?
|
Cognition | 2 | 2017 | 6770 | 0.030 |
Why?
|
Orbital Diseases | 1 | 1998 | 181 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 2017 | 286 | 0.030 |
Why?
|
Neuroprotective Agents | 1 | 2003 | 941 | 0.030 |
Why?
|
Europe | 3 | 1993 | 3338 | 0.030 |
Why?
|
Knee Joint | 1 | 2005 | 1680 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2006 | 2916 | 0.030 |
Why?
|
Disease Progression | 2 | 2006 | 13286 | 0.030 |
Why?
|
Eye Diseases | 1 | 2001 | 669 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 3799 | 0.030 |
Why?
|
Medical Records | 2 | 2012 | 1413 | 0.030 |
Why?
|
Postoperative Hemorrhage | 1 | 1999 | 412 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2861 | 0.030 |
Why?
|
Mitotic Index | 2 | 2010 | 172 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6598 | 0.030 |
Why?
|
Comorbidity | 2 | 2007 | 10388 | 0.030 |
Why?
|
Intelligence Tests | 2 | 1988 | 505 | 0.030 |
Why?
|
Astrocytes | 3 | 1992 | 1273 | 0.030 |
Why?
|
Suture Techniques | 3 | 1992 | 798 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2006 | 2732 | 0.030 |
Why?
|
Arteriovenous Fistula | 1 | 1979 | 315 | 0.030 |
Why?
|
Skull Fractures | 2 | 1989 | 195 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 199 | 0.030 |
Why?
|
Preoperative Period | 1 | 2017 | 550 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2002 | 1275 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1880 | 0.030 |
Why?
|
Weight Gain | 1 | 2005 | 2293 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 279 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2000 | 792 | 0.030 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 931 | 0.030 |
Why?
|
Motor Skills | 1 | 1998 | 522 | 0.030 |
Why?
|
Lactates | 1 | 1996 | 432 | 0.030 |
Why?
|
Science | 1 | 1997 | 241 | 0.030 |
Why?
|
Receptors, Growth Factor | 1 | 1996 | 334 | 0.030 |
Why?
|
Potassium Channels | 1 | 1998 | 563 | 0.030 |
Why?
|
Radiology, Interventional | 1 | 1999 | 460 | 0.030 |
Why?
|
Drug Delivery Systems | 2 | 2006 | 2219 | 0.030 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 18111 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 1998 | 560 | 0.030 |
Why?
|
Microinjections | 1 | 2015 | 327 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 1996 | 314 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 1998 | 577 | 0.030 |
Why?
|
Collagen | 2 | 1994 | 2688 | 0.030 |
Why?
|
Systems Integration | 1 | 2016 | 440 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2006 | 6366 | 0.030 |
Why?
|
Temperature | 1 | 2001 | 2204 | 0.030 |
Why?
|
Choline | 1 | 1996 | 493 | 0.030 |
Why?
|
Epilepsy | 6 | 2007 | 3310 | 0.030 |
Why?
|
Facial Paralysis | 2 | 1993 | 338 | 0.030 |
Why?
|
Leg | 1 | 1999 | 1116 | 0.030 |
Why?
|
Tamoxifen | 1 | 1999 | 981 | 0.030 |
Why?
|
Fetus | 2 | 1992 | 1880 | 0.030 |
Why?
|
Teratoma | 2 | 1988 | 395 | 0.030 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2015 | 277 | 0.030 |
Why?
|
Menopause | 1 | 2022 | 1626 | 0.030 |
Why?
|
Body Weight | 1 | 2005 | 4671 | 0.030 |
Why?
|
Safety | 1 | 1999 | 1186 | 0.030 |
Why?
|
Alanine | 1 | 1996 | 572 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2014 | 2453 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 868 | 0.030 |
Why?
|
Polymers | 1 | 2001 | 1621 | 0.030 |
Why?
|
Myelography | 2 | 1985 | 69 | 0.030 |
Why?
|
Models, Psychological | 1 | 1997 | 811 | 0.030 |
Why?
|
Receptor, erbB-2 | 2 | 1994 | 2417 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3595 | 0.030 |
Why?
|
Patient Care Planning | 1 | 1999 | 921 | 0.030 |
Why?
|
Lymphocytosis | 1 | 1994 | 119 | 0.030 |
Why?
|
Cadaver | 1 | 1997 | 1337 | 0.030 |
Why?
|
Intracranial Hypertension | 1 | 2015 | 186 | 0.030 |
Why?
|
Dihydroxyphenylalanine | 2 | 2006 | 76 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 21748 | 0.030 |
Why?
|
Cranial Nerve Diseases | 1 | 1993 | 112 | 0.030 |
Why?
|
Brachytherapy | 1 | 2001 | 1248 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 1999 | 976 | 0.030 |
Why?
|
Radiation Injuries | 2 | 1999 | 1180 | 0.030 |
Why?
|
Blindness | 1 | 1977 | 615 | 0.030 |
Why?
|
Survival Analysis | 2 | 2003 | 10252 | 0.030 |
Why?
|
Ethmoid Bone | 1 | 1992 | 35 | 0.030 |
Why?
|
Neoplasm Staging | 5 | 2003 | 11031 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1252 | 0.030 |
Why?
|
Drug Evaluation | 2 | 2006 | 647 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3020 | 0.030 |
Why?
|
Exons | 1 | 1998 | 2439 | 0.030 |
Why?
|
Registries | 3 | 2014 | 8091 | 0.030 |
Why?
|
Ghana | 1 | 1993 | 284 | 0.030 |
Why?
|
Military Personnel | 2 | 1999 | 1133 | 0.030 |
Why?
|
Laminin | 1 | 1994 | 419 | 0.030 |
Why?
|
Functional Laterality | 2 | 1997 | 2290 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2015 | 940 | 0.030 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 1994 | 232 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2015 | 651 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 1993 | 8300 | 0.030 |
Why?
|
Reference Standards | 1 | 1996 | 1025 | 0.030 |
Why?
|
Research | 1 | 2000 | 1999 | 0.030 |
Why?
|
Audiometry | 2 | 1983 | 241 | 0.030 |
Why?
|
Schools, Medical | 1 | 1998 | 881 | 0.030 |
Why?
|
Lumbosacral Region | 2 | 1997 | 310 | 0.030 |
Why?
|
Pilot Projects | 2 | 2016 | 8319 | 0.030 |
Why?
|
Adrenal Cortex | 1 | 2012 | 140 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 1572 | 0.020 |
Why?
|
Free Radicals | 1 | 1991 | 237 | 0.020 |
Why?
|
Fixatives | 1 | 2011 | 94 | 0.020 |
Why?
|
Oncogenes | 1 | 2017 | 1265 | 0.020 |
Why?
|
Odds Ratio | 2 | 2017 | 9849 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 1998 | 1222 | 0.020 |
Why?
|
Double-Blind Method | 4 | 2006 | 12025 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2004 | 3747 | 0.020 |
Why?
|
Molecular Biology | 1 | 1995 | 596 | 0.020 |
Why?
|
Warfarin | 1 | 1999 | 1497 | 0.020 |
Why?
|
DNA | 1 | 2005 | 7294 | 0.020 |
Why?
|
Lactic Acid | 1 | 1996 | 1132 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 1999 | 2480 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1002 | 0.020 |
Why?
|
Proteoglycans | 1 | 1994 | 837 | 0.020 |
Why?
|
Benzoquinones | 1 | 2011 | 201 | 0.020 |
Why?
|
Alternative Splicing | 1 | 1996 | 1117 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 1994 | 1107 | 0.020 |
Why?
|
Specimen Handling | 1 | 2015 | 694 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2012 | 9955 | 0.020 |
Why?
|
Immunotherapy | 1 | 2006 | 4446 | 0.020 |
Why?
|
Water | 2 | 1994 | 1395 | 0.020 |
Why?
|
Pituitary Hormones | 2 | 2006 | 183 | 0.020 |
Why?
|
Publishing | 1 | 1997 | 833 | 0.020 |
Why?
|
Basement Membrane | 1 | 1991 | 357 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16690 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 1998 | 1062 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2011 | 269 | 0.020 |
Why?
|
Cell Survival | 3 | 1987 | 5882 | 0.020 |
Why?
|
Decision Making | 2 | 2009 | 3888 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 1999 | 1239 | 0.020 |
Why?
|
Academies and Institutes | 1 | 1992 | 317 | 0.020 |
Why?
|
Pituitary Hormones, Anterior | 2 | 1998 | 65 | 0.020 |
Why?
|
Time | 1 | 2011 | 542 | 0.020 |
Why?
|
Nasal Mucosa | 1 | 1992 | 373 | 0.020 |
Why?
|
Neurofibromatosis 1 | 2 | 1986 | 570 | 0.020 |
Why?
|
Kinetics | 4 | 2011 | 6476 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 3001 | 0.020 |
Why?
|
Hearing | 2 | 1984 | 482 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1998 | 2865 | 0.020 |
Why?
|
Staining and Labeling | 3 | 1994 | 1101 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1157 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2022 | 3966 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1275 | 0.020 |
Why?
|
Monoamine Oxidase | 2 | 1986 | 178 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 1998 | 2419 | 0.020 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 1988 | 45 | 0.020 |
Why?
|
Diplopia | 1 | 2010 | 200 | 0.020 |
Why?
|
Base Sequence | 3 | 2014 | 12797 | 0.020 |
Why?
|
Surgical Procedures, Operative | 2 | 1999 | 1877 | 0.020 |
Why?
|
beta Catenin | 1 | 2014 | 1059 | 0.020 |
Why?
|
Drug Combinations | 1 | 1994 | 1958 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2005 | 11486 | 0.020 |
Why?
|
Clinical Trials as Topic | 4 | 2002 | 7914 | 0.020 |
Why?
|
Brain Edema | 1 | 2012 | 617 | 0.020 |
Why?
|
Cisterna Magna | 1 | 1987 | 41 | 0.020 |
Why?
|
Mutation | 3 | 2017 | 29786 | 0.020 |
Why?
|
Image Enhancement | 1 | 1999 | 2921 | 0.020 |
Why?
|
Cranial Nerve Injuries | 1 | 2007 | 25 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10943 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1988 | 425 | 0.020 |
Why?
|
Hemangiosarcoma | 1 | 1990 | 239 | 0.020 |
Why?
|
Injections, Spinal | 1 | 1988 | 303 | 0.020 |
Why?
|
Pneumonia | 1 | 1999 | 2133 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4185 | 0.020 |
Why?
|
Louisiana | 1 | 2007 | 108 | 0.020 |
Why?
|
Tissue Distribution | 2 | 2009 | 2327 | 0.020 |
Why?
|
China | 1 | 1993 | 2245 | 0.020 |
Why?
|
Fresh Water | 1 | 2007 | 83 | 0.020 |
Why?
|
Nerve Compression Syndromes | 2 | 1986 | 160 | 0.020 |
Why?
|
Scalp | 1 | 1970 | 380 | 0.020 |
Why?
|
Empty Sella Syndrome | 2 | 1983 | 14 | 0.020 |
Why?
|
Memory | 2 | 1988 | 2174 | 0.020 |
Why?
|
Medical Oncology | 1 | 1998 | 2267 | 0.020 |
Why?
|
Cell Line | 4 | 1991 | 16000 | 0.020 |
Why?
|
Nursing Methodology Research | 1 | 2006 | 67 | 0.020 |
Why?
|
Neurofibrils | 1 | 1986 | 76 | 0.020 |
Why?
|
Medulla Oblongata | 2 | 1985 | 243 | 0.020 |
Why?
|
Peritoneum | 1 | 1987 | 228 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2015 | 13814 | 0.020 |
Why?
|
Blood Platelets | 3 | 1986 | 2509 | 0.020 |
Why?
|
Thromboembolism | 1 | 2012 | 987 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 1970 | 839 | 0.020 |
Why?
|
Health Care Costs | 1 | 1999 | 3208 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2014 | 2307 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2003 | 4639 | 0.020 |
Why?
|
Contrast Media | 1 | 1999 | 5300 | 0.020 |
Why?
|
Vestibular Function Tests | 2 | 1985 | 127 | 0.020 |
Why?
|
Dysgerminoma | 1 | 1985 | 66 | 0.020 |
Why?
|
Gonadotropins, Pituitary | 1 | 2005 | 73 | 0.020 |
Why?
|
False Negative Reactions | 1 | 1986 | 588 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 1994 | 1736 | 0.020 |
Why?
|
Models, Theoretical | 1 | 1997 | 3589 | 0.020 |
Why?
|
Frontal Bone | 1 | 2005 | 105 | 0.020 |
Why?
|
Cerebellopontine Angle | 1 | 1985 | 55 | 0.020 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1985 | 148 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 2007 | 248 | 0.020 |
Why?
|
Disability Evaluation | 2 | 1999 | 1828 | 0.020 |
Why?
|
Torque | 1 | 2005 | 124 | 0.020 |
Why?
|
Meningitis | 2 | 1980 | 216 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2566 | 0.020 |
Why?
|
Diseases in Twins | 1 | 1986 | 449 | 0.020 |
Why?
|
Genes, Dominant | 1 | 1987 | 880 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 3519 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2009 | 602 | 0.020 |
Why?
|
Caloric Tests | 1 | 1983 | 10 | 0.020 |
Why?
|
Pneumoencephalography | 1 | 1983 | 22 | 0.020 |
Why?
|
Golgi Apparatus | 2 | 1988 | 410 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9445 | 0.010 |
Why?
|
Adenoma, Acidophil | 1 | 1983 | 3 | 0.010 |
Why?
|
Ganglioneuroma | 1 | 1984 | 57 | 0.010 |
Why?
|
Medical Errors | 1 | 2012 | 1297 | 0.010 |
Why?
|
Muscle Spasticity | 1 | 2005 | 154 | 0.010 |
Why?
|
S Phase | 1 | 2005 | 423 | 0.010 |
Why?
|
Hematoporphyrin Derivative | 1 | 1983 | 10 | 0.010 |
Why?
|
Facial Bones | 1 | 1985 | 201 | 0.010 |
Why?
|
Organometallic Compounds | 1 | 1987 | 665 | 0.010 |
Why?
|
Hospitals, Proprietary | 1 | 1983 | 39 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1998 | 3255 | 0.010 |
Why?
|
Frontal Lobe | 1 | 1970 | 1406 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4420 | 0.010 |
Why?
|
Infusions, Parenteral | 1 | 1983 | 419 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 6994 | 0.010 |
Why?
|
Injections, Intraventricular | 1 | 2003 | 231 | 0.010 |
Why?
|
Health Surveys | 2 | 1990 | 4036 | 0.010 |
Why?
|
Hearing Loss, Conductive | 1 | 1983 | 158 | 0.010 |
Why?
|
Facial Neoplasms | 1 | 1983 | 121 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4805 | 0.010 |
Why?
|
Anorexia | 1 | 2003 | 161 | 0.010 |
Why?
|
Audiometry, Evoked Response | 1 | 1981 | 44 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1994 | 2134 | 0.010 |
Why?
|
Microcirculation | 1 | 1986 | 1287 | 0.010 |
Why?
|
Cranial Nerve Neoplasms | 1 | 1982 | 129 | 0.010 |
Why?
|
Visual Acuity | 2 | 1983 | 2530 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1981 | 219 | 0.010 |
Why?
|
Mice, Nude | 1 | 1988 | 3689 | 0.010 |
Why?
|
Methotrexate | 1 | 1988 | 1728 | 0.010 |
Why?
|
Metyrapone | 1 | 1980 | 23 | 0.010 |
Why?
|
Ethylnitrosourea | 1 | 1981 | 51 | 0.010 |
Why?
|
Arylsulfotransferase | 3 | 1985 | 28 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1739 | 0.010 |
Why?
|
Orbital Neoplasms | 1 | 1983 | 225 | 0.010 |
Why?
|
Gonads | 1 | 1981 | 109 | 0.010 |
Why?
|
Pneumocephalus | 1 | 1981 | 46 | 0.010 |
Why?
|
Developing Countries | 1 | 1993 | 2815 | 0.010 |
Why?
|
Chronic Disease | 2 | 1993 | 9145 | 0.010 |
Why?
|
Fistula | 1 | 1982 | 220 | 0.010 |
Why?
|
Phosphorylation | 1 | 2012 | 8436 | 0.010 |
Why?
|
Counseling | 1 | 1988 | 1523 | 0.010 |
Why?
|
Hospital Costs | 1 | 2007 | 985 | 0.010 |
Why?
|
Light | 1 | 1986 | 1374 | 0.010 |
Why?
|
Cerebellar Cortex | 1 | 1981 | 107 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 1988 | 1901 | 0.010 |
Why?
|
Dianhydrogalactitol | 1 | 1979 | 3 | 0.010 |
Why?
|
Nausea | 1 | 2003 | 674 | 0.010 |
Why?
|
Sugar Alcohols | 1 | 1979 | 18 | 0.010 |
Why?
|
Foramen Magnum | 1 | 1979 | 36 | 0.010 |
Why?
|
Deep Brain Stimulation | 1 | 2007 | 748 | 0.010 |
Why?
|
Vomiting | 1 | 2003 | 637 | 0.010 |
Why?
|
Brain Stem | 1 | 1985 | 846 | 0.010 |
Why?
|
Receptors, Ghrelin | 1 | 1998 | 25 | 0.010 |
Why?
|
Vasopressins | 1 | 1980 | 370 | 0.010 |
Why?
|
Purkinje Cells | 1 | 1981 | 224 | 0.010 |
Why?
|
Kyphosis | 1 | 1981 | 237 | 0.010 |
Why?
|
Optic Nerve Diseases | 1 | 1982 | 327 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5867 | 0.010 |
Why?
|
Learning | 1 | 1988 | 1711 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 2 | 1990 | 228 | 0.010 |
Why?
|
Tomography | 1 | 1980 | 390 | 0.010 |
Why?
|
Hypothalamic Hormones | 1 | 1979 | 147 | 0.010 |
Why?
|
Paranasal Sinuses | 1 | 1981 | 250 | 0.010 |
Why?
|
Propranolol | 1 | 1980 | 502 | 0.010 |
Why?
|
Hemostatic Techniques | 1 | 1979 | 116 | 0.010 |
Why?
|
Ear, Inner | 1 | 1982 | 420 | 0.010 |
Why?
|
RNA Probes | 1 | 1998 | 113 | 0.010 |
Why?
|
Receptors, Somatostatin | 1 | 1998 | 129 | 0.010 |
Why?
|
Surgery, Plastic | 1 | 1985 | 624 | 0.010 |
Why?
|
Life Tables | 1 | 1998 | 370 | 0.010 |
Why?
|
Angiography | 1 | 1983 | 1639 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4463 | 0.010 |
Why?
|
Carcinoma, Basal Cell | 1 | 1983 | 545 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1983 | 1276 | 0.010 |
Why?
|
Sodium | 2 | 1995 | 1622 | 0.010 |
Why?
|
RNA, Antisense | 1 | 1998 | 138 | 0.010 |
Why?
|
Dopamine | 1 | 1984 | 1591 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1998 | 11525 | 0.010 |
Why?
|
Lomustine | 1 | 1977 | 59 | 0.010 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1983 | 770 | 0.010 |
Why?
|
Optic Chiasm | 1 | 1977 | 87 | 0.010 |
Why?
|
Ribonucleases | 1 | 1998 | 287 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1986 | 1856 | 0.010 |
Why?
|
Cyanides | 1 | 1977 | 83 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 1999 | 390 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14723 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 1998 | 20824 | 0.010 |
Why?
|
Activin Receptors | 1 | 1996 | 43 | 0.010 |
Why?
|
DNA Methylation | 1 | 2010 | 4285 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 1993 | 9647 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 1999 | 769 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6621 | 0.010 |
Why?
|
Emergencies | 1 | 1982 | 1170 | 0.010 |
Why?
|
Prednisone | 1 | 1980 | 1574 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1983 | 1504 | 0.010 |
Why?
|
Diarrhea | 1 | 2003 | 1348 | 0.010 |
Why?
|
Bone Diseases | 1 | 1979 | 416 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 1983 | 2700 | 0.010 |
Why?
|
Psychometrics | 1 | 1985 | 3003 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1999 | 2050 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 1986 | 2638 | 0.010 |
Why?
|
Etoposide | 1 | 1977 | 641 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1977 | 387 | 0.010 |
Why?
|
Inhibins | 1 | 1996 | 211 | 0.010 |
Why?
|
Luciferases | 1 | 1977 | 733 | 0.010 |
Why?
|
Oxygen | 1 | 1986 | 4189 | 0.010 |
Why?
|
Dogs | 1 | 1980 | 3912 | 0.010 |
Why?
|
Activins | 1 | 1996 | 208 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 1977 | 813 | 0.010 |
Why?
|
Follicle Stimulating Hormone, beta Subunit | 1 | 1994 | 58 | 0.010 |
Why?
|
Pain, Intractable | 1 | 1975 | 130 | 0.010 |
Why?
|
Transcription Factor Pit-1 | 1 | 1993 | 16 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 5974 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1995 | 346 | 0.010 |
Why?
|
Wounds, Nonpenetrating | 1 | 1980 | 795 | 0.010 |
Why?
|
Pressure | 1 | 1977 | 1203 | 0.010 |
Why?
|
Optic Nerve | 1 | 1977 | 554 | 0.010 |
Why?
|
Transcription Factors | 1 | 1993 | 12207 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 2274 | 0.010 |
Why?
|
Dementia | 1 | 1987 | 2518 | 0.010 |
Why?
|
Catheterization | 1 | 1979 | 1470 | 0.010 |
Why?
|
17-Ketosteroids | 1 | 1992 | 39 | 0.010 |
Why?
|
Depression | 1 | 2013 | 7759 | 0.010 |
Why?
|
NAD | 1 | 1977 | 590 | 0.010 |
Why?
|
Urea | 1 | 1995 | 450 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81201 | 0.010 |
Why?
|
Models, Biological | 1 | 1989 | 9584 | 0.010 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 1992 | 98 | 0.010 |
Why?
|
Exophthalmos | 2 | 1983 | 97 | 0.010 |
Why?
|
Plasminogen Activators | 1 | 1992 | 209 | 0.010 |
Why?
|
Transplantation, Homologous | 2 | 1991 | 4777 | 0.010 |
Why?
|
Molecular Probes | 1 | 1993 | 316 | 0.010 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 1992 | 238 | 0.010 |
Why?
|
Age of Onset | 1 | 1998 | 3270 | 0.010 |
Why?
|
Dehydroepiandrosterone | 1 | 1992 | 252 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1977 | 1375 | 0.010 |
Why?
|
Weight Loss | 1 | 2003 | 2625 | 0.010 |
Why?
|
Microvilli | 1 | 1991 | 241 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 1978 | 985 | 0.010 |
Why?
|
Gels | 1 | 1992 | 427 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1992 | 898 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 1991 | 270 | 0.010 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1991 | 225 | 0.010 |
Why?
|
Freeze Drying | 1 | 1970 | 98 | 0.010 |
Why?
|
Administration, Oral | 1 | 1998 | 3914 | 0.010 |
Why?
|
Vestibulocochlear Nerve | 1 | 1970 | 116 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1988 | 6364 | 0.010 |
Why?
|
Plasma Cells | 1 | 1994 | 591 | 0.010 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 1970 | 40 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 1985 | 3079 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 6234 | 0.010 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 1970 | 122 | 0.010 |
Why?
|
Fertility | 1 | 1994 | 781 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4925 | 0.010 |
Why?
|
Electric Stimulation Therapy | 1 | 1975 | 605 | 0.010 |
Why?
|
Microtomy | 1 | 1969 | 47 | 0.010 |
Why?
|
Menarche | 2 | 1983 | 516 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1988 | 18034 | 0.010 |
Why?
|
Data Collection | 1 | 1998 | 3339 | 0.010 |
Why?
|
Alzheimer Disease | 2 | 1987 | 8038 | 0.010 |
Why?
|
Endopeptidases | 1 | 1992 | 772 | 0.010 |
Why?
|
Regression Analysis | 1 | 1998 | 6459 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15535 | 0.000 |
Why?
|
Transforming Growth Factor beta | 1 | 1996 | 2007 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1969 | 424 | 0.000 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 1989 | 214 | 0.000 |
Why?
|
Probability | 1 | 1993 | 2506 | 0.000 |
Why?
|
Electrodes | 1 | 1970 | 619 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1983 | 4034 | 0.000 |
Why?
|
Neurons | 2 | 1984 | 9340 | 0.000 |
Why?
|
Dextrans | 1 | 1989 | 595 | 0.000 |
Why?
|
Ependymoma | 1 | 1970 | 334 | 0.000 |
Why?
|
Magnesium | 1 | 1970 | 813 | 0.000 |
Why?
|
Fibrosis | 1 | 1994 | 2029 | 0.000 |
Why?
|
Estradiol | 1 | 1994 | 2020 | 0.000 |
Why?
|
Selegiline | 1 | 1986 | 31 | 0.000 |
Why?
|
Lysosomes | 1 | 1991 | 893 | 0.000 |
Why?
|
Potassium | 1 | 1970 | 1336 | 0.000 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1986 | 158 | 0.000 |
Why?
|
Mitochondria | 2 | 1991 | 3514 | 0.000 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1985 | 147 | 0.000 |
Why?
|
Alkaline Phosphatase | 1 | 1969 | 867 | 0.000 |
Why?
|
Diagnostic Imaging | 1 | 2000 | 3508 | 0.000 |
Why?
|
Parathyroid Neoplasms | 1 | 1986 | 245 | 0.000 |
Why?
|
Drug Stability | 1 | 1985 | 291 | 0.000 |
Why?
|
Postmortem Changes | 1 | 1984 | 124 | 0.000 |
Why?
|
Health Facilities | 1 | 1989 | 572 | 0.000 |
Why?
|
Social Adjustment | 1 | 1986 | 631 | 0.000 |
Why?
|
Immunochemistry | 1 | 1983 | 124 | 0.000 |
Why?
|
Consciousness | 1 | 1989 | 572 | 0.000 |
Why?
|
Forehead | 1 | 1983 | 69 | 0.000 |
Why?
|
Thermodynamics | 1 | 1984 | 594 | 0.000 |
Why?
|
Corpus Callosum | 1 | 1987 | 737 | 0.000 |
Why?
|
Catechol O-Methyltransferase | 1 | 1984 | 245 | 0.000 |
Why?
|
Patient Discharge | 1 | 1995 | 3318 | 0.000 |
Why?
|
Endoplasmic Reticulum | 1 | 1988 | 1146 | 0.000 |
Why?
|
Maxilla | 1 | 1985 | 471 | 0.000 |
Why?
|
Blepharoptosis | 1 | 1983 | 143 | 0.000 |
Why?
|
Tongue | 1 | 1985 | 406 | 0.000 |
Why?
|
Cell Membrane | 1 | 1991 | 3749 | 0.000 |
Why?
|
Biological Assay | 1 | 1985 | 652 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1986 | 2556 | 0.000 |
Why?
|
Dietary Carbohydrates | 1 | 1986 | 905 | 0.000 |
Why?
|
Intelligence | 1 | 1986 | 920 | 0.000 |
Why?
|
Intracranial Pressure | 1 | 1982 | 326 | 0.000 |
Why?
|
Mandible | 1 | 1985 | 740 | 0.000 |
Why?
|
Pulse | 1 | 1980 | 229 | 0.000 |
Why?
|
Bone Transplantation | 1 | 1985 | 907 | 0.000 |
Why?
|
Osteotomy | 1 | 1985 | 822 | 0.000 |
Why?
|
Hot Temperature | 1 | 1985 | 1356 | 0.000 |
Why?
|
Leukopenia | 1 | 1979 | 213 | 0.000 |
Why?
|
Seasons | 1 | 1984 | 1493 | 0.000 |
Why?
|
Preanesthetic Medication | 1 | 1978 | 49 | 0.000 |
Why?
|
Ultrasonography | 1 | 1991 | 5984 | 0.000 |
Why?
|
Renin | 1 | 1980 | 642 | 0.000 |
Why?
|
Morbidity | 1 | 1983 | 1768 | 0.000 |
Why?
|
Hearing Loss | 1 | 1984 | 765 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1992 | 19233 | 0.000 |
Why?
|
Nasal Polyps | 1 | 1981 | 360 | 0.000 |
Why?
|
Electric Stimulation | 1 | 1981 | 1767 | 0.000 |
Why?
|
Prostheses and Implants | 1 | 1983 | 1387 | 0.000 |
Why?
|
Erythrocytes | 1 | 1984 | 2455 | 0.000 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1980 | 1240 | 0.000 |
Why?
|
Spine | 1 | 1981 | 1144 | 0.000 |
Why?
|
Radiographic Image Enhancement | 1 | 1977 | 885 | 0.000 |
Why?
|
Spinal Fusion | 1 | 1981 | 1241 | 0.000 |
Why?
|
Anticonvulsants | 1 | 1980 | 1916 | 0.000 |
Why?
|
Ischemic Attack, Transient | 1 | 1976 | 935 | 0.000 |
Why?
|
Blood Pressure | 1 | 1980 | 8551 | 0.000 |
Why?
|
Aging | 1 | 1980 | 8664 | 0.000 |
Why?
|